Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-019220
Filing Date
2025-07-15
Accepted
2025-07-15 17:18:45
Documents
1
Period of Report
2025-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3281
  Complete submission text file 0001127602-25-019220.txt   5033
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 160 SOUTH INDUSTRIAL BLVD CALHOUN GA 30701
Business Address
LEE STEVEN HYOSIG (Reporting) CIK: 0001855708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 251125656